AEON

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

AEON Biopharma, Inc.

NYSE MKT | AEON

0.97

USD

$0.00

(

0.00%

)

At Close (As of Nov 6, 2025)

$11.76M

Market Cap

-

P/E Ratio

-13.91

EPS

$64.80

52 Week High

$0.37

52 Week Low

HEALTHCARE

Sector

AEON Chart

Recent Chart
Price Action

AEON Technicals

Tags:

AEON Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income $73M
Selling General And Administrative $14M
Research And Development $14M
Operating Expenses -$73M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $97K
Income Before Tax $42M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations $42M
Comprehensive Income Net Of Tax -
Ebit -$28M
Ebitda -$28M
Net Income $42M

Revenue & Profitability

Earnings Performance

AEON Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $3.1M
Total Current Assets $1.6M
Cash And Cash Equivalents At Carrying Value $13K
Cash And Short Term Investments $13K
Inventory -
Current Net Receivables -
Total Non Current Assets $1.6M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.6M
Other Non Current Assets -
Total Liabilities $32M
Total Current Liabilities $14M
Current Accounts Payable $5.9M
Deferred Revenue -
Current Debt -
Short Term Debt $121K
Total Non Current Liabilities $18M
Capital Lease Obligations $1.3M
Long Term Debt $12M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $13M
Other Current Liabilities $7.5M
Other Non Current Liabilities $3.5M
Total Shareholder Equity -$29M
Treasury Stock -
Retained Earnings -$432M
Common Stock $4K
Common Stock Shares Outstanding $8K

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$20M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $97K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $15M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $42M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income $73M
Selling General And Administrative $14M
Research And Development $14M
Operating Expenses -$73M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $97K
Income Before Tax $42M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations $42M
Comprehensive Income Net Of Tax -
Ebit -$28M
Ebitda -$28M
Net Income $42M

AEON Profile

AEON Biopharma, Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

AEON Biopharma, Inc., headquartered in Newport Beach, California, is an innovative biopharmaceutical company focused on the development of advanced botulinum toxin products for various debilitating medical conditions. With a strong emphasis on proprietary formulations, AEON is well-positioned in the neuromodulators market, leveraging its robust pipeline to enhance treatment options and improve patient outcomes. The company is poised to capitalize on the increasing demand for effective therapeutic and aesthetic interventions, solidifying its role as a key player in the biopharmaceutical industry.

WORX
+33.21%
$0.38
YGMZ
+44.57%
$0.18
BIYA
+73.32%
$0.47
NVDA
-3.65%
$188.08
ASST
-0.68%
$1.45
EZGO
+37.90%
$0.20
BYND
-6.29%
$1.19
CHR
-14.86%
$0.06
SNAP
+9.72%
$8.01
MTC
+25.33%
$2.77
PFE
+0.97%
$24.85
TSLA
-3.49%
$445.91
AZI
+12.92%
$0.09
VHAI
0.00%
$0.00
RIVN
-1.29%
$15.22
PLUG
-4.92%
$2.50
SOFI
-9.67%
$27.16
DNN
-4.11%
$2.56
IOVA
+27.62%
$2.31
F
+0.07%
$13.12
ONDS
-12.50%
$5.25
PLTR
-6.83%
$175.05
WTO
-6.25%
$0.04
YDKG
0.00%
$0.05
INTC
-2.97%
$37.24
STGW
+16.83%
$5.62
T
+0.73%
$24.74
NIO
-1.78%
$7.16
BITF
-9.11%
$3.69
AXDX
-61.36%
$0.03
AAL
-2.01%
$13.15
AMD
-7.26%
$237.70
FTEL
-31.98%
$1.51
KVUE
+1.41%
$16.46
ACHR
-7.21%
$8.88
BURU
-6.81%
$0.27
BAC
+1.60%
$53.29
CIFR
-12.14%
$21.71
GRAB
-0.17%
$5.63
AAPL
-0.13%
$269.77
ADAP
-15.14%
$0.05
LYFT
+5.82%
$21.25
BTG
-5.70%
$3.80
HOOD
-10.80%
$127.08
IREN
-12.36%
$66.95
WBD
-1.49%
$22.42
IONZ
-7.99%
$3.80
ETHD
+8.25%
$4.84
RGTI
-7.85%
$34.36
AMZN
-2.86%
$243.04
NEHC
+6.52%
$6.04
NUAI
+6.52%
$6.04
NVO
-4.02%
$46.51
HIMS
-5.05%
$41.52
EPWK
+1.42%
$0.07
BTBT
-7.62%
$3.03
AMCR
+1.85%
$8.22
SOUN
-9.47%
$14.23
QBTS
-8.47%
$28.39
XPEV
+9.63%
$23.89
GPUS
-4.97%
$0.37
RMBL
+60.50%
$3.21
DVLT
-15.00%
$1.36
JOBY
-4.53%
$14.32
CELH
-24.79%
$45.06
MARA
-6.83%
$15.96
BMNR
-9.77%
$37.36
ADD
-25.47%
$0.05
RIG
0.00%
$3.90
RXRX
-6.85%
$4.62
CAN
-12.40%
$1.12
HL
+11.89%
$13.55
TLRY
-5.46%
$1.21
EOSE
+2.89%
$15.29
GOOGL
+0.15%
$284.75
IONQ
+3.64%
$57.43
SRM
+53.27%
$10.30
NOK
+0.87%
$6.91
DKNG
+0.21%
$27.98
WULF
-7.03%
$14.28
VALE
-0.64%
$12.23
RUBI
-26.47%
$0.22
BBD
-0.56%
$3.51
PINS
+2.05%
$26.28
SMCI
-4.03%
$40.33
PLTZ
+13.94%
$7.11
CMG
-4.41%
$30.56
MU
+0.34%
$238.33
ACVA
-37.54%
$5.09
VZ
+0.32%
$39.82
OSCR
-2.75%
$16.55
PLTD
+6.98%
$6.89
CCCS
-2.80%
$7.62
CCC
-2.80%
$7.62
NGD
+1.76%
$6.92
KHC
-1.73%
$23.72
KMX
-24.33%
$30.88
ABEV
-0.82%
$2.40
WLGS
-5.57%
$0.04
MRVL
+0.46%
$93.33
WORX
+33.21%
$0.38
YGMZ
+44.57%
$0.18
BIYA
+73.32%
$0.47
NVDA
-3.65%
$188.08
ASST
-0.68%
$1.45
EZGO
+37.90%
$0.20
BYND
-6.29%
$1.19
CHR
-14.86%
$0.06
SNAP
+9.72%
$8.01
MTC
+25.33%
$2.77
PFE
+0.97%
$24.85
TSLA
-3.49%
$445.91
AZI
+12.92%
$0.09
VHAI
0.00%
$0.00
RIVN
-1.29%
$15.22
PLUG
-4.92%
$2.50
SOFI
-9.67%
$27.16
DNN
-4.11%
$2.56
IOVA
+27.62%
$2.31
F
+0.07%
$13.12
ONDS
-12.50%
$5.25
PLTR
-6.83%
$175.05
WTO
-6.25%
$0.04
YDKG
0.00%
$0.05
INTC
-2.97%
$37.24
STGW
+16.83%
$5.62
T
+0.73%
$24.74
NIO
-1.78%
$7.16
BITF
-9.11%
$3.69
AXDX
-61.36%
$0.03
AAL
-2.01%
$13.15
AMD
-7.26%
$237.70
FTEL
-31.98%
$1.51
KVUE
+1.41%
$16.46
ACHR
-7.21%
$8.88
BURU
-6.81%
$0.27
BAC
+1.60%
$53.29
CIFR
-12.14%
$21.71
GRAB
-0.17%
$5.63
AAPL
-0.13%
$269.77
ADAP
-15.14%
$0.05
LYFT
+5.82%
$21.25
BTG
-5.70%
$3.80
HOOD
-10.80%
$127.08
IREN
-12.36%
$66.95
WBD
-1.49%
$22.42
IONZ
-7.99%
$3.80
ETHD
+8.25%
$4.84
RGTI
-7.85%
$34.36
AMZN
-2.86%
$243.04
NEHC
+6.52%
$6.04
NUAI
+6.52%
$6.04
NVO
-4.02%
$46.51
HIMS
-5.05%
$41.52
EPWK
+1.42%
$0.07
BTBT
-7.62%
$3.03
AMCR
+1.85%
$8.22
SOUN
-9.47%
$14.23
QBTS
-8.47%
$28.39
XPEV
+9.63%
$23.89
GPUS
-4.97%
$0.37
RMBL
+60.50%
$3.21
DVLT
-15.00%
$1.36
JOBY
-4.53%
$14.32
CELH
-24.79%
$45.06
MARA
-6.83%
$15.96
BMNR
-9.77%
$37.36
ADD
-25.47%
$0.05
RIG
0.00%
$3.90
RXRX
-6.85%
$4.62
CAN
-12.40%
$1.12
HL
+11.89%
$13.55
TLRY
-5.46%
$1.21
EOSE
+2.89%
$15.29
GOOGL
+0.15%
$284.75
IONQ
+3.64%
$57.43
SRM
+53.27%
$10.30
NOK
+0.87%
$6.91
DKNG
+0.21%
$27.98
WULF
-7.03%
$14.28
VALE
-0.64%
$12.23
RUBI
-26.47%
$0.22
BBD
-0.56%
$3.51
PINS
+2.05%
$26.28
SMCI
-4.03%
$40.33
PLTZ
+13.94%
$7.11
CMG
-4.41%
$30.56
MU
+0.34%
$238.33
ACVA
-37.54%
$5.09
VZ
+0.32%
$39.82
OSCR
-2.75%
$16.55
PLTD
+6.98%
$6.89
CCCS
-2.80%
$7.62
CCC
-2.80%
$7.62
NGD
+1.76%
$6.92
KHC
-1.73%
$23.72
KMX
-24.33%
$30.88
ABEV
-0.82%
$2.40
WLGS
-5.57%
$0.04
MRVL
+0.46%
$93.33
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.